Similarly, tetrandrine (TET) as a P-glycoprotein (P-gp) inhibitor works in T2DM (Shan et al., 2013) and reduces tau aggregation by rescuing lysosomal Ca2+ homeostasis in AD (Tong et al., 2022). The gene discussed is MAPT; the disease is Alzheimer disease.